310
Participants
Start Date
April 30, 2024
Primary Completion Date
June 30, 2024
Study Completion Date
December 31, 2024
Immunoscore Colon Test
"Immunoscore Colon is an in-vitro diagnostic test, allowing the quantification of CD3 and CD8 positive cells in formalin-fixed paraffin-embedded (FFPE) tissue samples of primary colon cancer.~The test uses immunohistochemistry, digital pathology techniques and a dedicated image analysis software to determine CD3+ and CD8 + cell densities in the tumor ant in the invasive margin of the tumor."
AP-HP - hôpital européen Georges-Pompidou, Paris
National Cancer Institute, France
OTHER_GOV
Ministry of Health, France
OTHER_GOV
Assistance Publique - Hôpitaux de Paris
OTHER